Novel Drug Delivery Systems for Cancer Therapy Market

Novel Drug Delivery Systems for Cancer Therapy Market contains market size and forecasts of Novel Drug Delivery Systems for Cancer Therapy in Global, including the following market information:

Global Novel Drug Delivery Systems for Cancer Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Novel Drug Delivery Systems for Cancer Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Embolization Particles ? Drug Eluting Beads Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Novel Drug Delivery Systems for Cancer Therapy include Advanced Medical Isotope Corporation, Bind Therapeutics, Boston Scientific Corporation, BTG plc, CeloNova BioSciences, Inc., Cook Medical, Inc., Cospheric LLC, Covidien, plc and Eckert & Ziegler BEBIG, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Novel Drug Delivery Systems for Cancer Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Novel Drug Delivery Systems for Cancer Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Novel Drug Delivery Systems for Cancer Therapy Market Segment Percentages, by Type, 2021 (%)

Embolization Particles ? Drug Eluting Beads

Polyvinyl Alcohol Particles

Microspheres

Gelatin-Based Embolization Devices

Selective Internal Radiation Therapy

Holmium-Based Microspheres

Liquid Embolics ? Onyx

Other

Global Novel Drug Delivery Systems for Cancer Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Novel Drug Delivery Systems for Cancer Therapy Market Segment Percentages, by Application, 2021 (%)

Hospitals

Clinics

Others

Global Novel Drug Delivery Systems for Cancer Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Novel Drug Delivery Systems for Cancer Therapy Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Novel Drug Delivery Systems for Cancer Therapy revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Novel Drug Delivery Systems for Cancer Therapy revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Advanced Medical Isotope Corporation

Bind Therapeutics

Boston Scientific Corporation

BTG plc

CeloNova BioSciences, Inc.

Cook Medical, Inc.

Cospheric LLC

Covidien, plc

Eckert & Ziegler BEBIG

EmboMedics, Inc.

Kobo Products, Inc.

Merit Medical Systems, Inc.

Mo-Sci Corporation

Nanobiotix

Polysciences, Inc.

Sirtex Medical, Inc.

Terumo Corporation